Related Experiment Video
Updated: Apr 11, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.9K
Triptan use among hospital workers affected by migraine
G Viticchi1, L Falsetti, L Buratti
1Neurologic Clinic, Marche Polytechnic University, Via Conca 1, 60020, Ancona, Italy, giovanna.viticchi@libero.it.
Summary
Hospital workers, including physicians, underuse triptans for migraine attacks. This indicates a gap in knowledge about effective migraine treatment, potentially leading to complications like chronic migraine.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Triptans are the most effective specific treatment for migraine attacks.
- Despite their efficacy, triptans are underused in clinical practice.
- Healthcare professionals, particularly physicians, should have optimal knowledge of migraine management.
Purpose of the Study:
- To assess the appropriate use of triptan therapy among hospital workers with migraine.
- To investigate if hospital employees correctly manage their migraine attacks with suitable therapies.
- To identify potential gaps in knowledge regarding migraine treatment among healthcare professionals.
Main Methods:
- A 1-year study involving 1250 hospital employees.
- Structured interviews and questionnaires assessed headache characteristics and treatments.
- Data on drug use (triptans vs. NSAIDs) and work activity were collected and analyzed using Chi-squared tests.
Main Results:
- 20.3% of participants (254) had migraine.
- Triptan use was significantly lower than non-steroidal anti-inflammatory drugs (NSAIDs) (p < 0.0001).
- Only 10.7% of migraineur physicians used triptans, showing a significant difference in drug distribution (p < 0.0001).
Conclusions:
- Hospital workers, including physicians, demonstrate reduced use of triptans for migraine management.
- This suggests inadequate dissemination of knowledge regarding optimal migraine treatment strategies.
- Incorrect therapeutic approaches can increase risks of drug abuse and migraine chronification.
Related Concept Videos
01:26Cholinergic Antagonists: Therapeutic Uses
1.8K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.8K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
889
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
889
01:29Venous Thrombosis III: Interprofessional Care
471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
01:24Cholinergic Antagonists: Pharmacokinetics
1.1K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.1K
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
2.2K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.2K